Neuromyelitis optica is a variant of multiple sclerosis

Archives of Neurology

Volumn 64, Issue 6, 2007, Pages 901-903

  Galetta, Steven L ^a   Bennett, Jeffrey ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DEMYELINATING DISEASE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; PLEOCYTOSIS; PRIORITY JOURNAL; SPINAL CORD;

HISTORY, 19TH CENTURY; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA;

EID: 34250323064     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.6.901     Document Type: Article

References (18)

1. Devic ME. Myelite subaigue compliquee de nevrite optique. Bull Med (Paris). 1895;8:1033-1034.
2. Wingerchuk DM, Hogancamp W, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome) Neurology. 1999;53:1107-1114.
3. Weinshenker BG. Neuromyelitis optica: what it is and what it might be. Lancet. 2003;361:889-890.
4. Lennon VA, Wingerchuck DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106-2112.
5. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised criteria for neuromyelitis optica. Neurology. 2006;66:1485-1489.
6. Cabrera-Gomez JA, Gonzalez YR, Corominas MC, et al. Relapsing neuromyelitis optica syndrome is a prevalent disease in Cuba: an epidemiological study. Neurology. 2005;64:A38.
7. Cabrera-Gomez JA, Gonzalez YR, Lara R, et al. Neuromyelitis optica syndrome in Cuba: a prospective clinical study of 54 cases. Neurology. 2005;64:A38.
8. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal MS binds to the aquaporin 4 water channel. J Exp Med. 2005;202:473-477.
9. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002;125:1450-1461.
10. Frigeri A, Gropper MA, Turck CW, Verkman AS. Immunolocalization of the mercurial-insensitive water channel and glycerol intrinsic protein in epithelial cell plasma membranes. Proc Natl Acad Sci U S A. 1995;92:4328-4331.
11. Weinshenker BG, Wingerchuk DM, Vukusic S, et al. NMO predicts relapse longitudinally extensive idiopathic transverse myelitis. Ann Neurol. 2006;59:566-569.
12. Wingerchuk DM, Weinshenker B. Neuromyelitis optica: clinical predictors of relapsing course and survival. Neurology. 2003;60:848-853.
13. Hummers LK, Krishnan C, Casciola-Rosen L, et al. Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology. 2004;62:147-149.
14. Ghezzi A, Bergamaschi R, Martinelli V, et al. Clinical characteristics, course and prognosis of relapsing Devic's neuromyelitis optica. J Neurol. 2004;251:47-52.
15. Pittock SJ, Lennon VA, Wingerchuk DM, Krecke K, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica (NMO). Arch Neurol. 2006;63:390-396.
16. Pittock SJ, Weinshenker BG, Lucchinetti CF, et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006;63:964-968.
17. Lucchinetti C, Bruck W, Parisis J, Schiethauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000;47:707-717.
18. Misu T, Miyagi S, Kakita A, et al. A comparative neuropathological analysis of Japanese cases of neuromyelitis optica and multiple sclerosis [abstract]. Neurology. 2005;64:A39.